Align Technology (ALGN)
(Delayed Data from NSDQ)
$280.32 USD
+2.24 (0.81%)
Updated May 15, 2024 04:00 PM ET
After-Market: $280.23 -0.09 (-0.03%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$280.32 USD
+2.24 (0.81%)
Updated May 15, 2024 04:00 PM ET
After-Market: $280.23 -0.09 (-0.03%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth C Momentum C VGM
Zacks News
Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.
CVS Health Gains on Pharmacy Services, Strategic Buyouts
by Zacks Equity Research
On Jun 8, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).
Hologic Wins FDA Approval for Genius 3D Mammography Exam
by Zacks Equity Research
Hologic, Inc. (HOLX) continues to expand its Breast and Skeletal Health business through innovation and product development.
Zimmer Biomet Rides on Spine Business, Knee Challenges Stay
by Zacks Equity Research
On Jun 6, we issued an updated research report on Warsaw, IN-based Zimmer Biomet Holdings Inc. (ZBH).
Bruker Grows on NMR & Nano Businesses amid Several Odds
by Zacks Equity Research
On Jun 6, we issued an updated research report on Billerica, MA-based Bruker Corporation (BRKR), a manufacturer of proprietary life science and materials research systems.
Boston Scientific Wins CE Mark for Vercise Gevia DBS System (revised)
by Zacks Equity Research
Generally, DBS therapy is a surgical procedure of placing a device that stimulates specific areas in the brain using electrical signals.
Cardiovascular Systems Innovation On Track, Competition Rife
by Zacks Equity Research
On Jun 6, we issued an updated research report on St. Paul, MN-based Cardiovascular Systems, Inc. (CSII).
Here's Why You Should Bet on Humana (HUM) Stock Right Now
by Zacks Equity Research
Louisville-based Humana Inc. (HUM), one of the largest health care plan providers in the United States, has been an investor favorite, given its strong fundamentals
Medtronic SureTune3 Obtains Health Canada License for DBS
by Zacks Equity Research
Medtronic plc (MDT) recently announced the receipt of Health Canada license for SureTune 3 software for deep brain stimulation (DBS).
Boston Scientific Wins CE Mark for Vercise Gevia DBS System
by Zacks Equity Research
Boston Scientific Corporation (BSX) recently won CE mark for its Vercise Gevia Deep Brain Stimulation (DBS) System.
HealthEquity (HQY) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity Inc (HQY) reported earnings of 19 cents per share in the first quarter of fiscal 2018, higher than the Zacks Consensus Estimate of 16 cents.
Amedisys (AMED) Prospects Impressive Amid Tough Competition
by Zacks Equity Research
On Jun 5, we issued an updated research report on leading molecular diagnostic company, Amedisys, Inc. (AMED).
Abiomed (ABMD) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Abiomed, Inc. (ABMD), scaled a new 52-week high of $142.95 on Jun 5, eventually closing a bit lower at $141.81.
Edwards Lifesciences (EW) SAPIEN 3 THV Gets FDA Approval
by Zacks Equity Research
Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for aortic and mitral valve-in-valve procedures using SAPIEN 3 transcatheter heart valve (THV).
Tenet Healthcare Prices New Notes to Repay Existing Debts
by Zacks Equity Research
Tenet Healthcare Corporation (THC) recently priced the previously announced private offering of newly issued notes.
QIAGEN Strengthens Cancer Research Foothold on New License
by Zacks Equity Research
QIAGEN N.V. (QGEN) has received a worldwide license for biomarkers to be used in identifying patients who may have benefited from immune-oncology (I-O) therapies in cancer treatment.
Myriad Genetics BRACAnalysis CDx in OlympiAD Results Positive
by Zacks Equity Research
Myriad Genetics, Inc. (MYGN), a leading molecular diagnostics and personalized medicine company recently unveiled positive data pertaining to its BRACAnalysis CDx test.
Align Sets Up Manufacturing Center in China, Grows in APAC
by Zacks Equity Research
Align Technology (ALGN) has recently inaugurated a new Invisalign treatment planning facility in Chengdu, China.
Abbott Laboratories at 52-Week High on Product Line, Buyouts
by Zacks Equity Research
Share price of IL-based Abbott Laboratories (ABT) scaled a new 52-week high of $46.55 on Jun 2, eventually closing a bit lower at $46.50.
QIAGEN & Bristol-Myers Squibb Partner on Cancer Research
by Zacks Equity Research
QIAGEN N.V. (QGEN) has made significant advancement in the field of cancer research through the use of its revolutionary next-generation sequencing (NGS) technology.
Five Stocks Rocketing Higher on Huge Momentum
by David Bartosiak
The bears were sent running, screaming towards their caves today as the market started strong and didn???t look back at all
Align Technology Upgrades iTero Element Intraoral Scanners
by Zacks Equity Research
Based in California, leading dental product maker Align Technology, Inc. (ALGN) recently announced a software upgrade to its iTero Element intraoral scanners.
UnitedHealth Unit Taps Connecticut Orthopedic Surgery Market
by Zacks Equity Research
Surgical Care Affiliates, Inc, a part of UnitedHealth Group's Optum unit, recently partnered with Western Connecticut Orthopedic Surgery Center by making an equity investment in the latter.
Why WellCare (WCG) Stock Should Be in Your Portfolio Now
by Zacks Equity Research
Leading managed care company WellCare Health Plans, Inc.'s (WCG) business strategies should continue to support growth.
Align Technology Rises with Invisalign, SmartTrack Patents
by Zacks Equity Research
Align Technology (ALGN) has received two U.S. Patents from the United States Patent and Trademark Office (USPTO) for its SmartTrack clear aligner material.
Quest Diagnostics Poised on Solid Q1 Results Despite Woes
by Zacks Equity Research
On May 22, we issued an updated research report on Quest Diagnostics, Inc. (DGX), a major commercial laboratory services provider.